/assets/images/provider/photos/2839207.png)
Tardive dyskinesia (TD) is a movement disorder that can develop as a side effect of certain long-term psychiatric medications, particularly antipsychotics. It causes involuntary, repetitive movements that may affect the face, mouth, tongue, or other parts of the body.
While TD can sound concerning, early recognition and proper management can significantly improve outcomes.
Symptoms of TD can vary in severity and may include:
These movements are typically uncontrollable and may become more noticeable over time.
Tardive dyskinesia is most commonly associated with long-term use of medications that affect dopamine levels in the brain, including:
Not everyone who takes these medications will develop TD, but the risk increases with duration of use and individual sensitivity.
Some individuals may have a higher risk of developing TD, including:
Yes—tardive dyskinesia is treatable, especially when identified early.
Treatment options may include:
A provider may adjust, reduce, or switch medications when appropriate.
FDA-Approved Treatments
There are medications specifically designed to treat TD symptoms.
Ongoing Monitoring
Regular follow-ups can help detect early signs and prevent progression.
It is important not to stop medication suddenly without medical guidance.
Recognizing symptoms early allows for quicker intervention and better outcomes. Patients and families should feel comfortable reporting any unusual movements or changes.
At My Wellness Psychiatry, we prioritize regular monitoring and open communication to ensure safe, effective treatment.